corporate site

※Please note that the actual color of the product may appear slightly different depending on your device setting.
※The above crude drug photos are for illustrative purposes only.

Tsumura-Kampo Jumihaidokuto Extract Granules

Category 2 OTC medicines

PRODUCT INFORMATION

INDICATIONS

Following symptoms in persons with moderate physical strength who have skin disease with redness which is sometimes suppurating: Early stage of suppurative or acute skin disease, rash, eczema/dermatitis, and athlete’s foot.

INGREDIENTS

2 packets (3.75 g) of this medicine contain 1.75 g of Jumihaidokuto extract of the following mixed crude drugs;

JP Platycodon Root 1.5 g
JP Bupleurum Root 1.5 g
JP Cnidium Rhizome 1.5 g
JP Poria Sclerotium 1.5 g
JP Quercus Bark 1.5 g
JP Aralia Rhizome 0.75 g
JP Saposhnikovia Root 0.75 g
JP Glycyrrhiza 0.5 g
JP Schizonepeta Spike 0.5 g
JP Ginger 0.5 g

(JP: The Japanese Pharmacopoeia)
Inactive ingredients: JP Magnesium Stearate, JP Lactose Hydrate.

DOSAGE

Take the following dosages with water or warm water before a meal.

Age One dosage Daily dosage
15 years and over 1 packet(1.875 g) 2 times a day
7-14 years 2/3 packet
4-6 years 1/2 packet
2-3 years 1/3 packet
Less than 2 years Do not use

[Cautions] This medication should be given to children only under adult supervision

PRECAUTIONS FOR HANDLING

PRECAUTIONS FOR STRAGE AND HANDLING

  1. Store in a cool, dry place free from direct sunlight.

  2. Keep all medication out of the reach of children.

  3. When you take this medicine in divided dose, fold over the opened edge of the packet and store it. The remaining medicine should be taken within 2 days.

  4. Since the medicine contains crude drugs, the granules color may vary for individual products, however this has no influence on the efficacy of this medicine.

  5. Do not take this medicine after the expiration date.

CAUTION FOR USE

Who should seek consultation

  1. The following persons should consult a physician, pharmacist, or registered distributor before taking this medicine.

    1. Persons undergoing medical treatment from a physician.
    2. Pregnant women or women suspected of being pregnant.
    3. Persons who is physically weak (declining of strength or constitutional weakness).
    4. Persons who have gastrointestinal weakness.
    5. Persons who have experienced rash, redness, itching, etc. due to medicines or something.

  2. Stop taking this medicine and consult a physician, pharmacist or registered distributor if symptoms do not improve after taking this medicine for about 1 month (about 1 week if you take this medicine for the early phase of suppurative or acute skin disease). Take this leaflet with you.

  3. Stop taking this medicine and consult a physician, pharmacist or registered distributor if symptoms may make progress after taking this medicine. Take this leaflet with you.

Production of this product has been approved for domestic sales in accordance with the Pharmaceutical Affairs Law of Japan.